• Gliapharm SA

    GE
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-550.1.166.424-0
    Sector: Research and development

    Age of the company

    8 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    106'200

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Gliapharm SA

    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company. Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices. Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings. Find out more

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Gliapharm SA

    • Gliapharm SA is currently active and the industry «Research and development». The legal headquarters are in Genève.
    • The management of the company Gliapharm SA consists of 4 persons.
    • The last commercial register change was made on 05.08.2022. All changes can be viewed under the section «Notifications» and saved as a PDF.
    • The company Gliapharm SA is registered under the UID CHE-193.477.382.
    • There are 11 other active companies that have registered an identical address. These include: EBRAINS, Bruxelles, succursale de Genève, FONDATION AGALMA, Fondation Campus Biotech Geneva.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language) Customise the company purpose with just a few clicks.

    La Société a pour but la recherche, le développement et la commercialisation de substances pharmaceutiques visant à traiter les maladies neurologiques (pour but complet cf. statuts).

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    PricewaterhouseCoopers SA
    Genève 05.08.2022

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Past and translated company names

    • Gliapharm AG
    • Gliapharm Ltd
    Would you like to update the company name? Click here.

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Gliapharm SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 220805/2022 - 05.08.2022
    Categories: Change in capital, Change in management, Change of auditors

    Publication number: HR02-1005536180, Commercial Registry Office Geneva, (660)

    Gliapharm SA, à Genève, CHE-193.477.382 (FOSC du 31.05.2019, p. 0/1004642292). Par décision du 30.06.2022, l'assemblée générale a modifié la clause statutaire introduite le 26.07.2016 en matière d'augmentation conditionnelle du capital-participation;
    pour les détails voir les statuts. Création d'un capital-participation, fondée sur la clause statutaire relative à la création d'un capital-participation conditionnel, introduite par l'assemblée générale du 26.07.2016 et modifiée le 30.06.2022, d'un montant de CHF 6'200, par l'émission de 6'200 bons de participation de CHF 1 chacun, nominatifs, liés selon les statuts.

    Capital-participation:
    CHF 6'200, entièrement libéré, divisé en 6'200 bons de CHF 1, nominatifs, liés selon statuts. Statuts modifiés le 30.06.2022. Finsterwald Charles est maintenant domicilié à Crassier.

    Organe de révision:
    PricewaterhouseCoopers SA (CHE-390.062.0059), à Genève. Radiation de la mention de renonciation au contrôle restreint.

    SOGC 190531/2019 - 31.05.2019
    Categories: Change in capital

    Publication number: HR02-1004642292, Commercial Registry Office Geneva, (660)

    Gliapharm SA, à Genève, CHE-193.477.382 (FOSC du 19.12.2017, p. 0/3942039). Le capital-actions de CHF 100'000 a été libéré ultérieurement à concurrence de CHF 50'000.

    Capital-actions:
    CHF 100'000, entièrement libéré, divisé en 100'000 actions des CHF 1, nominatives, liées selon statuts. Statuts modifiés le 23.05.2019. Finsterwald Charles et Magistretti Ambroise sont maintenant domiciliés, respectivement, à Veyrier et à Pully.

    SOGC 246/2017 - 19.12.2017
    Categories: Change of company address

    Publication number: 3941787, Commercial Registry Office Vaud, (550)

    Gliapharm SA, Lausanne, CHE-193.477.382 (FOSC du 08.08.2016, p. 0/2993165). La société ayant transféré son siège à Genève, la raison de commerce est radiée d'office du Registre du commerce du canton de Vaud.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm